Skip to:

Sanghyuk Shin

Adjunct Assistant Professor

Departments

DepartmentsType of Faculty
EpidemiologyFull Time
Contact Information
Phone: 
310.825.1293

650 Charles E. Young Drive South
BOX 951772, 71-269A CHS
Los Angeles, CA 90095-1772

Areas of Interest: 

molecular epidemiology of tuberculosis, TB/HIV co-infection, infectious diseases, social determinants of health, statistical evaluation of biomarkers, molecular diagnostics, migrant health, international health, relationship between smoking and TB, program evaluation, public health practice, disease surveillance

Dr. Sanghyuk Shin is an infectious disease epidemiologist with expertise in molecular epidemiology, global health, and statistical evaluation of diagnostic performance. His educational background includes a PhD in Public Health (Global Health track) from the Joint Doctoral Program at San Diego State University/University California San Diego and a Master of Science in Epidemiology at the Harvard School of Public Health. He also completed a Postdoctoral Fellowship in Global HIV/AIDS Prevention Research at UCLA David Geffen School of Medicine. His prior experience includes epidemiological research in China, Mexico, Somalia, and Botswana. Dr. Shin also worked on infectious disease surveillance projects at the New York City Office of AIDS Surveillance and California Emerging Infections Program. Dr. Shin is currently the PI for an NIH Career Development Award on molecular epidemiology of tuberculosis in Botswana (K01AI118559). He also collaborates with Los Angeles County Tuberculosis Control Program on TB prevention projects for communities at high risk for TB in Los Angeles County.

Education: 
PhD
This faculty member is available to serve as: 
Masters Advisor
MS Report Committee Member
Field Studies Advisor

Please check with the faculty member or their office about availability to serve during current academic period.

Selected Publications: 
  1. Shin SS, Xiao D, Cao M, Chen W, Li Q, Chai W, Lindsay RP, Usita P, Novotny TE.  Patient and doctor perspectives on incorporating smoking cessation into tuberculosis care in Beijing, China. Int J Tuberc Lung Dis 2012;16(1):126-131.

  2. Shin SS, Gallardo M, Lozada R, Abramovitz D, Burgos JL, Laniado-Laborin R, Rodwell T, Novotny TE, Strathdee SA, Garfein RS. Cigarette smoking intensity and interferon gamma release assay conversion among persons who inject drugs: a cohort study. Pulm Med 2012: 828106. doi:10.1155/2012/828106. PMCID: PMC3529865.

  3. Shin SS, Wan X, Wang Q, Raymond HF, Liu L, Ding D, Yang G, Novotny TE. Perceived discrimination and smoking among rural-to-urban migrant women in China. J Immigr Minor Health 2013;15(1):132-140. doi 10.1007/s10903-012-9599-1. PMCID: PMC354498.

  4. Shin SS, Gonzalez Moreno P, Rao S, Garfein RS, Novotny TE, Strathdee SA. Cigarette smoking and quit attempts among injection drug users in Tijuana, Mexico. Nicotine Tob Res 2013;15(12):2060-8. doi:10.1093/ntr/ntt099. PMCID: PMC3819980.

  5. Shin SS, Laniado-Laborin R, Gonzalez Moreno P, Novotny TE, Strathdee SA, Garfein RS. Dose-response association between salivary cotinine levels and Mycobacterium tuberculosis infection. Int J Tuberc Lung Dis 2013;17(11):1452-1458. PMCID: PMC3801225.

  6. Shin SS. Two Koreas and public health: “First, do no harm”. Int J Epidemiol 2014;43:1341-1342. doi: 10.1093/ije/dyu014. PMCID: PMC4258767Lindsay RP, Shin SS, Garfein RS, Rusch M, Novotny TE. The association between active and passive smoking and latent tuberculosis infection in adults and children in the United State: results from NHANES. PLoS One 2014; 9(3): e93137. doi: 10.1371/journal.pone.0093137. PMCID: PMC3963991.

  7. Zetola NM. Shin SS, Tumedi K, Moeti K, Ncube R, Nicol M, Collman R, Klausner J, Modongo C. Mixed Mycobacterium tuberculosis complex infections and false negative results for GeneXpert MTB/RIF rifampin-resistance are associated with poor clinical outcomes. J Clin Microbiol 2014;52(7):2422-2429. doi:10.1128/JCM.02489-13. PMCID: PMC4097703.

  8. Zetola NM. Macesic N, Modongo C, Peloso A, Shin SS, Ncube R, Collman R. Longer hospital stay is associated with higher rates of tuberculosis-related morbidity and mortality within 12 months after discharge in a referral hospital in Sub-Saharan Africa. BMC Infect Dis 2014;14:409. doi:10.1186/1471-2334-14-409. PMCID: PMC4223402.

  9. Loeb S, Sanda MG, Broyles DL, Shin SS, Bangma CH, Wei JT, Partin AW, Klee GG, Slawin KM, Marks LS, van Schaik RHN, Chan DW, Sokoll LJ, Cruz AB, Mizrahi IA, Catalona WJ. The Prostate Health Index (phi) selectively identifies clinically-significant prostate cancer. J Urol 2015 Apr;193(4):1163-9. doi:10.1016/j.juro.2014.10.121.

  10. Shin SS, Modongo C, Ncube R, Sepako E, Klausner JD, Zetola NM. Advanced immune suppression is associated with increased prevalence of mixed-strain Mycobacterium tuberculosis infections among persons at high risk for drug-resistant TB in Botswana. J Infect Dis 2015;211(3):347-51. doi:10.1093/infdis/jiu421. PMCID: PMC4351373.